- McCain's
presidential campaign in Maine.
Served as
outside director of
ImmuCell Corporation since 1995. He
became chief executive officer of Education...
- in Portland. Unum, Covetrus,
TruChoice Federal Credit Union, M&T Bank,
ImmuCell Corp, and
Pioneer Telephone have
headquarters here, and Portland's neighboring...
-
April 2020.
Sacituzumab govitecan-hziy was
approved based on the
results of
IMMU-132-01, a multicenter, single-arm
clinical trial (NCT01631552) of 108 parti****nts...
-
doxorubicin to form an antibody-drug
conjugate or ADC (known as hLL1-Dox or
IMMU-110) for
treatment of
relapsed multiple myeloma. A
Phase I/II
clinical trial...
- (October 24, 2011). "The
humanized anti-HLA-DR moAb,
IMMU-114,
depletes APCs and
reduces alloreactive T
cells:
implications for
preventing GVHD". Nature. 47...
- in
order vectorise the
antigen to
dendritic cells.
Currently Immutep are only
focus on the
ImmuFact and
ImmuTune platforms.
Eftilagimod alpha (lab names:...
- This drug was
developed by Immunomedics, Inc. and was
originally known as
IMMU-106. In
August 2015 the US FDA
granted it
orphan drug
status for
immune thrombocytopenia...
-
includes NKp44".
European Journal of Immunology. 33 (2): 567–77. doi:10.1002/
immu.200310033. PMID 12645956. S2CID 27147251.
Bleharski JR,
Kiessler V, Buonsanti...
-
metastatic TNBC.
Three early stage trials reported TNBC
results in June 2016, for
IMMU-132, Vantictumab, and
atezolizumab in
combination with the
chemotherapy nab-pa****axel...
- "Costimulation of
human CD28- T
cells by 4-1BB ligand".
European Journal of Immunology. 33 (2): 446–54. doi:10.1002/
immu.200310020. PMID 12645943. S2CID 38395011...
